Skip to main content
Caplight Logo









Fusion Biotechnology

Fusion Biotechnology

Private
UlsanHealthcare & Life Scienceshttp://fusionbiotechnology.com/

Last Round

Grant

Mar 18, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Fusion Biotechnology is a biotechnology company that develops chemical and biological drugs for degenerative and intractable diseases using a proprietary protein-substrate docking platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

senolyticstargeted drug deliveryprotein-drug conjugationanti-aging therapeuticsbiopharmaceutical R&DnanomedicinePRODOKdrug discovery platformrecombinant proteinprecision medicinelongevity biotechoncology therapeuticsbiotech licensingprotein engineeringdrug delivery platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fusion Biotechnology Comparables

Compare Fusion Biotechnology with similar companies based on industry and business-model similarity.

Fusion Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cleara Biotech
80%
Oisín Biotechnologies
78%
Rubedo Life Sciences
77%

Fusion Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 18, 2026
GrantOct 18, 2025
GrantNov 28, 2024
GrantJul 16, 2022

Fusion Biotechnology Investors

Notable investors and investment history

Fusion Biotechnology investors
InvestorRounds
Ministry of Science and ICT of South KoreaGrant
National Research Foundation of KoreaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 18, 2026

    Received funding from Korea Health Industry Development Institute and National Research Foundation of Korea.

  • Oct 18, 2025

    Received funding from Korea Institute of Science and Technology and Ministry of Science and ICT.

Fusion Biotechnology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fusion Biotechnology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fusion Biotechnology's valuation, stock price, and market status.

Firmographic Details

HeadquartersUlsan
Year Founded2018
Last FundingMar 18, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?